Search

everythinglearnresearchcommunity

for

Search:↓

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Some skin diseases and their treatments can negatively affect male fertility.

Skin problems like excessive hair growth, acne, and dark skin patches can be signs of Polycystic Ovarian Disease, which may also be linked to family history and a risk for diabetes.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

The document says that there are treatments for hair and nail diseases.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.

The review highlights the importance of stem cells in hair health and suggests new treatment strategies for hair loss conditions.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Many young Egyptian women with PCOS also have fatty liver disease, especially if they are overweight and insulin resistant.

Mutations in certain receptors can cause diseases and offer new treatment options.

New drugs are improving treatment for hormone-related diseases in small pets.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Inositol was more effective than metformin in improving menstrual cycles and pregnancy rates in PCOS patients.

A young woman with kidney failure had hair loss due to a common hormonal disorder, which improved with hormone therapy.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

People distressed by minor skin changes should consult dermatologists with cosmetic expertise, and a public Cosmetic Dermatology Service with mental health support is recommended.

The document concludes that various skin conditions have specific treatments, ranging from antihistamines for urticaria to surgery and medication for tumors and chronic skin diseases.

The document concludes that individualized treatments for hair issues are effective, certain hair changes can indicate neurocutaneous diseases, specific lotions improve skin health, laser hair removal works but needs more study on long-term effects, men's cosmetics are diverse, peeling is effective but can have side effects, and facial pigmentation is often due to overactive skin cells.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and budesonide, which improved after stopping the medications.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and inhaled budesonide.

Injecting steroids like Triamcinolone Acetonide for skin treatments can cause Cushing's Syndrome.

Two patients treated with TAC for mouth fibrosis improved but developed Cushing's Syndrome symptoms.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.